Judith Bruchfeld Selected Research

Judith Bruchfeld Research Topics

14	Tuberculosis (Tuberculoses) 01/2021 - 11/2014
7	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 05/2010
6	Infections 04/2021 - 05/2011
4	Rheumatoid Arthritis 01/2021 - 11/2014
4	Extensively Drug-Resistant Tuberculosis 07/2020 - 02/2016
2	Reinfection 12/2021 - 07/2021
2	Pulmonary Tuberculosis 11/2021 - 01/2019
2	Latent Tuberculosis 01/2021 - 01/2019
2	HIV Infections (HIV Infection) 11/2014 - 05/2002
1	Coinfection 12/2021
1	Postural Orthostatic Tachycardia Syndrome 04/2021
1	Hemolysis 11/2020
1	Ankylosing Spondylitis 10/2018
1	Psoriatic Arthritis 10/2018
1	Necrosis 12/2015
1	Silicosis 12/2015
1	Immune Reconstitution Inflammatory Syndrome 02/2015
1	Latent Infection 11/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2014
1	Genomic Instability 01/2011

17	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
4	FluoroquinolonesIBA 01/2020 - 02/2016
3	Biological ProductsIBA 01/2021 - 06/2015
3	lipoarabinomannan (LAM)IBA 01/2021 - 01/2015
3	Tuberculin (PPD)IBA 01/2020 - 01/2012
2	Pyrazinamide FDA LinkGeneric 11/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2019
2	AntigensIBA 01/2020 - 01/2012
2	InterferonsIBA 01/2020 - 11/2014
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2019 - 01/2018
2	bedaquiline (R207910)IBA 01/2019 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019 - 01/2011
2	GoldIBA 11/2014 - 05/2011
2	Interferon-gamma (Interferon, gamma)IBA 01/2012 - 07/2011
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	GlycolipidsIBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Prothionamide (Protionamide)IBA 11/2020
1	rifapentine (Priftin)FDA Link 01/2019
1	N 30IBA 01/2018
1	EnzymesIBA 11/2014
1	dimemorfan (AT 17)IBA 11/2014
1	Interleukin-12 (IL 12)IBA 01/2012
1	Interleukin-13IBA 01/2012
1	ChemokinesIBA 01/2012
1	Interleukin-17 (Interleukin 17)IBA 01/2012
1	CytokinesIBA 01/2012
1	Interleukin-2 (IL2)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	MitogensIBA 05/2011

2	Therapeutics 10/2018 - 06/2015
1	Ambulatory Care (Outpatient Care) 04/2021
1	Aftercare (After-Treatment) 01/2018
1	Transplantation 12/2015
1	Biological Therapy 06/2015
1	Art Therapy 02/2015
1	Stem Cell Transplantation 11/2014
1	Drug Therapy (Chemotherapy) 11/2014